查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1785939

全球心臟人工智慧监测与诊断市场

Cardiac Artificial Intelligence Monitoring and Diagnostics
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 202 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟人工智慧监测和诊断市场规模将达到 57 亿美元

全球心臟AI监测和诊断市场规模预计在2024年达到13亿美元，预计在分析期内（2024-2030年）将以27.5%的复合年增长率增长，到2030年将达到57亿美元。心臟AI监测和诊断硬体是本报告分析的细分市场之一，预计在分析期结束时，其复合年增长率将达到30.5%，达到33亿美元。心臟AI监测和诊断软体细分市场在分析期间的复合年增长率预计将达到25.0%。

美国市场规模估计为 3.466 亿美元，中国市场预计复合年增长率为 25.9%

美国心臟人工智慧监测和诊断市场规模预计在2024年达到3.466亿美元。预计在分析期间（2024-2030年），全球第二大经济体中国市场的复合年增长率将达到25.9%，到2030年市场规模将达到8.504亿美元。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为25.5%和23.4%。在欧洲，预计德国市场的复合年增长率约为18.7%。

全球心臟人工智慧监测和诊断市场—主要趋势和驱动因素摘要

为什么心臟人工智慧监测和诊断的需求越来越大？

由于心血管疾病的发生率不断上升、对早期精准检测的需求日益增长，以及主导医疗解决方案的不断进步，对心臟人工智慧监测和诊断的需求也日益增长。冠状动脉疾病、心臟衰竭和心律不整等心臟病仍然是全球范围内的主要死亡原因。传统的诊断方法虽然有效，但往往需要耗时的解读，并且容易出现人为错误。人工智慧监测系统和诊断工具正在透过提供更快、更准确、更即时的心臟健康状况洞察，彻底改变心血管护理。

穿戴式医疗技术、远端患者监护和人工智慧辅助影像的兴起，使得心臟诊断更加便利、更具主动性。人工智慧驱动的心电图解读、心臟衰竭预测分析以及自动心律不整检测，正在帮助临床医生做出明智的决策，同时减轻医疗服务提供者的负担。此外，将人工智慧融入远端保健和数位健康平台，可以实现早期疗育，尤其是对高风险患者，从而减少住院治疗并改善患者预后。随着医疗保健系统向预测性和预防性心臟病学转型，人工智慧主导的心臟诊断的应用预计将得到扩展。

科技进步如何改善心臟 AI 监测和诊断？

人工智慧、深度学习和穿戴式感测器技术的创新正在提高心臟监测和诊断的准确性、效率和可及性。其中最重要的进展之一是人工智慧增强心电图 (ECG) 的开发，它能够高精度地检测复杂的心臟疾病，例如心房颤动、心室心搏过速和心肌梗塞。人工智慧驱动的心电图演算法可以即时分析大量数据，减少诊断错误并提高早期检出率。

另一项重大突破是将人工智慧融入心血管影像程序，例如超音波心动图、心臟核磁共振和 CT血管造影术。人工智慧影像解决方案可帮助放射科医师和心臟科医师识别异常、量化心臟功能并更有效地评估冠状动脉疾病。此外，穿戴式人工智慧心臟监测仪（如智慧型手錶和生物感测器）可提供持续、即时的心臟健康监测，在症状变得严重之前提醒使用者和医疗保健提供者註意潜在风险。机器学习模型也正在开发中，以预测心臟病的进展并根据患者特定数据制定个人化治疗计划。随着人工智慧技术的不断发展，其在心臟护理中的作用将变得更加突出，提高准确性、效率和早期疾病检测。

哪些市场趋势推动了心臟 AI 监测和诊断产业的发展？

人工智慧在远端医疗和远端患者监护中的日益普及，是塑造心臟人工智慧市场最具影响力的趋势之一。随着虚拟医疗的兴起，人工智慧驱动的心臟监测设备能够在家中持续追踪心臟健康状况，减少频繁就诊的需求。这一趋势对于管理慢性心臟疾病和高风险患者尤其重要，因为即时人工智慧分析可以在心律不整导致严重併发症之前检测到它们。

影响市场成长的另一个关键趋势是人工智慧在个人化医疗中的扩展。人工智慧主导的分析被用于根据个别患者数据量身定制治疗计划，并改善心臟病患者的治疗效果。此外，製药公司正在利用人工智慧优化心血管药物研发，并将人工智慧进一步融入更广泛的心臟护理生态系统。心臟病学巨量资料的兴起，加上云端基础的人工智慧解决方案，使得医疗专业人员之间能够无缝共用数据并进行即时协作，从而增强患者照护。随着人工智慧诊断技术的不断改进，其与医院工作流程的整合度也不断提高，人工智慧驱动的心臟监测正成为循环系统医疗保健的常态。

影响心臟 AI 监测和诊断市场未来发展的关键成长动力有哪些？

心臟人工智慧监测和诊断市场的成长受到多种关键因素的推动，包括心血管疾病盛行率的上升、人工智慧演算法的进步以及数位医疗基础设施的不断扩展。其中一个关键成长要素是心臟病负担的增加，这推动了对早期检测、预测分析和持续监测解决方案的需求。人工智慧主导的诊断工具可以缩短诊断心臟病所需的时间，从而加快干预速度并改善患者预后。

影响市场的另一个关键驱动因素是医疗机构对人工智慧诊断解决方案的监管核准和采用日益增多。各国政府和监管机构已经认识到人工智慧在心臟病学领域的潜力，从而加大了对人工智慧研究和数位医疗政策的投资。此外，人工智慧穿戴装置的价格实惠、普及性强，加上人工智慧可解释性的提升，使得心臟监测更方便患者使用且更具可扩展性。随着人工智慧与医疗保健的融合不断加速，心臟人工智慧监测和诊断市场预计将迎来显着增长，并彻底改变全球心臟病的检测、预防和管理。

部分

产品类型（心臟AI监测和诊断硬体、心臟AI监测和诊断软体、心臟AI监测和诊断服务）、类型（心臟诊断、心臟监测）、应用（心律不整应用、中风应用、缺血性心臟疾病应用、狭窄应用、其他应用）、最终用途（医院最终用途、专科诊所最终用途、诊断中心最终用途、其他最终用途）

受访公司范例

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips NV
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

人工智慧集成

全球产业分析师利用可操作的专家内容和人工智慧工具改变市场和竞争情报。

Global 特定产业产业SLM 的典型规范，而是建立了一个从世界各地专家收集的内容库，包括影片录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地和进出口（成品和原始设备製造商）情况预测其竞争地位的变化。这种复杂而多面的市场动态预计将以多种方式影响竞争对手，包括销货成本(COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 其他欧洲国家
  • 亚太地区
  • 其他地区

第四章 竞赛

简介目录
Product Code: MCP29823

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market to Reach US$5.7 Billion by 2030

The global market for Cardiac Artificial Intelligence Monitoring and Diagnostics estimated at US$1.3 Billion in the year 2024, is expected to reach US$5.7 Billion by 2030, growing at a CAGR of 27.5% over the analysis period 2024-2030. Cardiac AI Monitoring & Diagnostics Hardware, one of the segments analyzed in the report, is expected to record a 30.5% CAGR and reach US$3.3 Billion by the end of the analysis period. Growth in the Cardiac AI Monitoring & Diagnostics Software segment is estimated at 25.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$346.6 Million While China is Forecast to Grow at 25.9% CAGR

The Cardiac Artificial Intelligence Monitoring and Diagnostics market in the U.S. is estimated at US$346.6 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$850.4 Million by the year 2030 trailing a CAGR of 25.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 25.5% and 23.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 18.7% CAGR.

Global Cardiac Artificial Intelligence Monitoring and Diagnostics Market - Key Trends & Drivers Summarized

Why Is the Demand for Cardiac Artificial Intelligence Monitoring and Diagnostics Increasing?

The demand for cardiac artificial intelligence monitoring and diagnostics is rising due to the increasing prevalence of cardiovascular diseases, the need for early and accurate detection, and advancements in AI-driven healthcare solutions. Heart diseases, including coronary artery disease, heart failure, and arrhythmias, remain the leading cause of mortality worldwide. Traditional diagnostic methods, while effective, often require time-consuming interpretation and are prone to human error. AI-powered monitoring systems and diagnostic tools are transforming cardiovascular care by providing faster, more precise, and real-time insights into heart health.

The rise of wearable health technology, remote patient monitoring, and AI-assisted imaging has made cardiac diagnostics more accessible and proactive. AI-powered ECG interpretation, predictive analytics for heart failure, and automated detection of arrhythmias are helping clinicians make informed decisions while reducing the burden on healthcare providers. Additionally, the integration of AI in telehealth and digital health platforms allows for early intervention, particularly in high-risk patients, reducing hospitalizations and improving patient outcomes. As healthcare systems shift towards predictive and preventive cardiology, the adoption of AI-driven cardiac diagnostics is expected to expand.

How Are Technological Advancements Improving Cardiac AI Monitoring and Diagnostics?

Innovations in artificial intelligence, deep learning, and wearable sensor technology are enhancing the accuracy, efficiency, and accessibility of cardiac monitoring and diagnostics. One of the most significant advancements is the development of AI-enhanced electrocardiograms (ECGs) that can detect complex cardiac conditions such as atrial fibrillation, ventricular tachycardia, and myocardial infarctions with high accuracy. AI-powered ECG algorithms can analyze vast amounts of data in real-time, reducing diagnostic errors and improving early detection rates.

Another major breakthrough is the integration of AI in cardiovascular imaging, including echocardiography, cardiac MRI, and CT angiography. AI-driven imaging solutions assist radiologists and cardiologists in identifying abnormalities, quantifying heart function, and assessing coronary artery disease more efficiently. Additionally, wearable AI-powered cardiac monitors, such as smartwatches and biosensors, provide continuous, real-time heart health monitoring, alerting users and healthcare providers to potential risks before symptoms become critical. Machine learning models are also being developed to predict heart disease progression and personalize treatment plans based on patient-specific data. As AI technology continues to evolve, its role in cardiac care will become even more prominent, improving accuracy, efficiency, and early disease detection.

Which Market Trends Are Driving Growth in the Cardiac AI Monitoring and Diagnostics Industry?

The increasing adoption of AI in telemedicine and remote patient monitoring is one of the most influential trends shaping the cardiac artificial intelligence market. With the rise of virtual healthcare, AI-powered cardiac monitoring devices are enabling continuous, at-home heart health tracking, reducing the need for frequent hospital visits. This trend is particularly important for managing chronic heart conditions and high-risk patients, as real-time AI analytics can help detect irregularities before they lead to severe complications.

Another key trend influencing market growth is the expansion of AI in personalized medicine. AI-driven analytics are being used to tailor treatment plans based on individual patient data, improving outcomes for those with heart disease. Additionally, pharmaceutical companies are leveraging AI to optimize drug discovery for cardiovascular treatments, further integrating AI into the broader ecosystem of cardiac care. The rise of big data in cardiology, along with cloud-based AI solutions, is enabling seamless data sharing and real-time collaboration between healthcare professionals, enhancing patient care. As AI-driven diagnostics continue to improve, they are increasingly being integrated into hospital workflows, making AI-powered cardiac monitoring a standard in cardiovascular healthcare.

What Are the Key Growth Drivers Shaping the Future of the Cardiac AI Monitoring and Diagnostics Market?

The growth in the cardiac artificial intelligence monitoring and diagnostics market is driven by several key factors, including rising cardiovascular disease prevalence, advancements in AI algorithms, and the expansion of digital health infrastructure. One of the primary growth drivers is the increasing burden of heart disease, prompting the need for early detection, predictive analytics, and continuous monitoring solutions. AI-driven diagnostic tools reduce the time required for heart disease diagnosis, allowing for faster interventions and improved patient outcomes.

Another crucial driver shaping the market is the increasing regulatory approvals and adoption of AI-powered diagnostic solutions by healthcare institutions. Governments and regulatory bodies are recognizing the potential of AI in cardiology, leading to greater investments in AI research and digital healthcare policies. Additionally, the affordability and accessibility of AI-driven wearables, coupled with improved AI interpretability, are making cardiac monitoring more patient-friendly and scalable. As AI integration in healthcare continues to accelerate, the cardiac AI monitoring and diagnostics market is expected to witness substantial growth, revolutionizing heart disease detection, prevention, and management worldwide.

SCOPE OF STUDY:

The report analyzes the Cardiac Artificial Intelligence Monitoring and Diagnostics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Cardiac AI Monitoring and Diagnostics Hardware, Cardiac AI Monitoring and Diagnostics Software, Cardiac AI Monitoring and Diagnostics Services); Type (Cardiac Diagnostics, Cardiac Monitoring); Application (Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application, Stenosis Application, Other Applications); End-Use (Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • Aidoc Medical Ltd.
  • AliveCor, Inc.
  • Arterys Inc.
  • Boston Scientific Corporation
  • CardiAI
  • Cardio Diagnostics
  • Cardiologs Technologies
  • Cleerly, Inc.
  • DiA Imaging Analysis
  • Eko Health Inc.
  • GE HealthCare Technologies Inc.
  • HeartVista, Inc.
  • Idoven
  • iRhythm Technologies, Inc.
  • Koninklijke Philips N.V.
  • Medtronic plc
  • RSIP Vision
  • Siemens Healthineers AG
  • Tempus AI, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Cardiac Artificial Intelligence Monitoring and Diagnostics - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Cardiovascular Disease Burden Throws the Spotlight on AI-Powered Cardiac Monitoring Systems
    • Integration of AI in ECG, Imaging, and Wearables Propels Growth in Real-Time Diagnostic Capabilities
    • Early Detection and Risk Stratification Capabilities Expand the Addressable Market for AI Cardiac Tools
    • AI Algorithms for Arrhythmia, Heart Failure, and Ischemia Enhance Diagnostic Precision and Speed
    • Telecardiology Adoption Accelerates Demand for Remote AI-Driven Monitoring Platforms
    • Healthcare Shift Toward Predictive Analytics Strengthens the Business Case for AI Diagnostics
    • Wearable and Ambulatory Monitoring Devices Integrated with AI Spur Out-of-Hospital Cardiac Care Growth
    • Smart Hospitals and Digital Health Ecosystems Fuel Demand for AI-Based Clinical Decision Support Tools
    • AI-Powered Imaging Interpretation Drives Efficiency in Echocardiography and Cardiac MRI/CT Analysis
    • Regulatory Approvals of AI Software-as-Medical-Device (SaMD) Create New Commercial Pathways
    • Cardiology Workflow Optimization through AI Reduces Diagnostic Time and Clinical Burden
    • Collaborations Between MedTech and AI Startups Accelerate Product Innovation and Market Entry
    • Growing Role of AI in Population Health Management and Preventive Cardiology Supports Market Adoption
    • AI Model Transparency, Validation, and Explainability Become Critical in Regulatory and Clinical Acceptance
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Cardiac Artificial Intelligence Monitoring and Diagnostics Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Hardware by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Software by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Cardiac AI Monitoring & Diagnostics Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Cardiac Arrhythmias Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Cardiac Arrhythmias Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Stroke Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Stroke Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Ischemic Heart Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Ischemic Heart Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Stenosis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Stenosis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 24: World Recent Past, Current & Future Analysis for Diagnostic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 25: World 6-Year Perspective for Diagnostic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World 6-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 28: World Recent Past, Current & Future Analysis for Cardiac Diagnostics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 29: World 6-Year Perspective for Cardiac Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 30: World Recent Past, Current & Future Analysis for Cardiac Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 31: World 6-Year Perspective for Cardiac Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 34: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 35: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 36: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 37: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 38: USA Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CANADA
    • TABLE 40: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 41: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 42: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 44: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 46: Canada Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 47: Canada 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • JAPAN
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 48: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 49: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 50: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 52: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 54: Japan Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Japan 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • CHINA
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 56: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 58: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 59: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 60: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 61: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 62: China Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: China 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • EUROPE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 64: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 65: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 66: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 68: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 70: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 72: Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • FRANCE
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 74: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 76: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 77: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 78: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 79: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 80: France Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: France 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • GERMANY
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 82: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 83: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 84: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 85: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 86: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 88: Germany Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 89: Germany 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ITALY
    • TABLE 90: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 91: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 92: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 94: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 95: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 96: Italy Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 97: Italy 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • UNITED KINGDOM
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 98: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 100: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 101: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 102: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 103: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 104: UK Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: UK 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 107: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 109: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 112: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 113: Rest of Europe 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Cardiac Artificial Intelligence Monitoring and Diagnostics Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 115: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 119: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 120: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 121: Asia-Pacific 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 122: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Product Type - Percentage Breakdown of Value Sales for Cardiac AI Monitoring & Diagnostics Hardware, Cardiac AI Monitoring & Diagnostics Software and Cardiac AI Monitoring & Diagnostics Services for the Years 2025 & 2030
    • TABLE 124: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 125: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Application - Percentage Breakdown of Value Sales for Other Applications, Cardiac Arrhythmias Application, Stroke Application, Ischemic Heart Disease Application and Stenosis Application for the Years 2025 & 2030
    • TABLE 126: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 127: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use, Diagnostic Centers End-Use and Other End-Uses for the Years 2025 & 2030
    • TABLE 128: Rest of World Recent Past, Current & Future Analysis for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Cardiac Diagnostics and Cardiac Monitoring - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of World 6-Year Perspective for Cardiac Artificial Intelligence Monitoring and Diagnostics by Type - Percentage Breakdown of Value Sales for Cardiac Diagnostics and Cardiac Monitoring for the Years 2025 & 2030

IV. COMPETITION